 |
Altasciences Clinical Research is a mid-sized contract research organization that encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS and Algorithme Pharma USA in Fargo, ND, with an overall company focus on supporting early-stage drug development. With over 25 years of industry experience, Altasciences provides clinical services to an international customer base of biopharmaceutical companies. Altasciences’ full-service solutions offering in this critical stage of drug development includes clinical pharmacology, medical writing, biostatistics, data management and bioanalysis.
Booth #: 201
|
|
BioPharma Services Inc is a client-focused, regulatory-inspected contract research organization specializing in Bioequivalence studies and Phase I/IIa (including Abuse Liability, Alcohol and DD Interaction, FIM, SAD/MAD) Clinical Trials, with a total of 300 beds split between our clinical sites in Canada and the USA. We are a physician-owned, full-service provider with support services in Regulatory and Scientific Affairs, PK Design and Support, Medical Writing, Data Management/Biostatistics and Bioanalytical services.
Booth #: 404
|
 |
Clinical Pharmacology of Miami Inc (CPMI), an ERG Portfolio Company, has completed over 1,900 studies in their newly-renovated Phase 1 facility. Equipped with 120 beds, CPMI specializes in NHV and specialized populations including hepatic impairment, renal insufficiency, hypertension, sexual dysfunction, obesity, diabetes and NASH. Trial expertise includes FIH, SAD/MAD, PK/PD, BE/BA, QTc/TQT, DDI and Food Interaction. Four successful FDA inspections.
Evolution Research Group is the largest, independent site network in the US with a focus on neuroscience, early phase and special populations.
Booth #: 203
|
|
High Point Clinical Trials Center has provided comprehensive (Phase I-III) clinical site services since 2008. Our 42,000 ft2 facility consists of three unique units for the execution of outpatient and inpatient clinical studies. In addition to healthy normal Phase I studies, we focus on specialty populations such as Metabolic Diseases, NASH, Renal Respiratory, CNS, Cardiovascular and Nicotine.
Booth #: 305
|
|
ALPHADAS® is a compelling end-to-end software solution that expedites key drug development decision making and provides operational savings throughout the business. Stop by and learn why ALPHADAS has become the standard by which organizations around the world accelerate and streamline early-phase clinical trial operations and services.
Booth #: 401
|
|
Lixoft was founded in 2011 and is based on a seven-year research program on biostatistics and modeling led by the Inria Institute. Lixoft sells advanced software applications for the modeling and simulation of drug development and clinical trials.
Booth #: 302
|
|
Metrum Research Group LLC is the leading innovator in biomedical modeling and simulation. We have provided strategic decision making with the highest quality of scientific expertise for 150+ companies on over 450 projects. Visit our exhibit booth to learn about how we aim to defeat disease by taking a quantitative approach to drug development. Ask about job openings, METWORX (our cloud-based platform) and mrgsolve (our R package for simulations from ODE-based models).
Booth #: 101
|
|
NOCCR and VRG are privately-owned, multispecialty clinical research centers which are members of the Alliance for Multispecialty Research. NOCCR-Knoxville is a fully-equipped Phase I Unit with 50 beds and 24,500+ sq ft of space located within the University of Tennessee Medical Center. This unit excels at FIH, procedurally-complex trials and special populations. VRG and NOCCR-New Orleans primarily conduct later-phase studies in a broad array of therapeutic areas.
Booth #: 403
|
 |
Nuventra is a drug development consulting firm specializing in Pharmacokinetics, Pharmacodynamics and Pharmacometrics. Our 30+ consultants, most with 15-30 years of experience, serve as a virtual extension of your team. More than just providing results from an analysis, our group helps make those results actionable and provides strategic guidance throughout your development program.
Booth #: 402 |
|
qPharmetra LLC, a global leader in pharmacometric modeling and clinical pharmacology consulting, uses quantitative methods to help drug development organizations choose the best dose, design efficient trials and develop analyses supporting positive regulatory reviews. Our clinical pharmacology services help drug development organizations develop their clinical pharmacology plans, analyze preclinical PK/PD data to support candidate selection and to design Phase 1 trials effectively advancing your development programs. We work with companies of all sizes at all development stages to model better medicines.
Booth #: 303
|
|
Rudraya Corp is a leading provider of Cloud Computing, Data Management and Visualizations Platform (SONIC) supporting Drug Discovery at Pharmaceutical, Biotechnology and Healthcare organizations. Eight out of the top ten pharma companies are our customers, using SONIC to perform cutting-edge genomics, machine learning, modeling, clinical trial simulation, bioinformatics and other computation workflows.
Booth #: 304
|
|
Simulations Plus Inc is the premier developer of modeling & simulation solutions supporting drug discovery and development. With subsidiary companies Cognigen Corp & DILIsym Services, we provide easy-to-use software (including GastroPlus™, ADMET Predictor™, KIWI™ and DILIsym®) and PBPK modeling, pharmacometrics and systems toxicology/pharmacology consulting services to assist with safety risk assessment and preclinical/clinical development efforts.
Booth #: 301
|
|
Spaulding Clinical Research is a global CRO based in West Bend, Wisconsin providing Phase I – IV drug development services to the pharmaceutical and biotechnology industries. Spaulding Clinical operates a 200-bed Clinical Pharmacology Unit, a Full-service Biometrics Group and Cardiac Core Laboratory.
Booth #: 103 |
|
TNO will exhibit the latest developments on the use of microtracer-labeled drugs in clinical pharmacology. Besides the use of microtracers to establish absolute bioavailability, the application of the automated AMS analysis, combined with simultaneous direct hrMS/MS for metabolite profiling, will be shown.
Booth #: 104
|